ANCA practice in diagnostic pathology: state of play and unresolved challenges
The ANCA Laboratory Practices Meeting, a satellite of the 22nd International Vasculitis Workshop (Melbourne, 22 February 2026), convened laboratory scientists, pathologists and clinicians to discuss current ANCA testing practices. Delegates described divergent practices. Three themes emerged. First, high-quality MPO- and PR3-ANCA immunoassays are the preferred first-line test for ANCA-associated vasculitis. At diagnosis, harmonisation of ANCA interpretation through likelihood ratios and test-result intervals may offer a practical way to improve result interpretation and comparability despite differences in analytical platforms. Second, whilst antigen-specific immunoassays have better overall test characteristics for vasculitis, they have not rendered ANCA indirect immunofluorescence (IIF) redundant. ‘Typical’ ANCA patterns add value both in supporting pattern concordance with MPO- and PR3-ANCA for ANCA-associated vasculitis, and in raising suspicion for drug-induced vasculitis when discordant. ‘Atypical’ patterns, on the other hand may be helpful in the diagnosis of autoimmune liver diseases and inflammatory bowel disease. Inter-laboratory agreement on pattern classification remains suboptimal. A classification system for ANCA IIF modelled on the International Consensus on ANA Patterns (ICAP) would be beneficial. Third, testing in low pre-test probability population consumes laboratory resources, and increases the risk of non-specific results. Choosing the appropriate indication for ANCA testing, whether diagnosis of vasculitis, monitoring of established disease, or investigation of gastrointestinal and hepatobiliary disease, ultimately rests with the requesting clinician. Laboratories can offer distinct requesting items to direct each request to the most appropriate testing algorithm. However, adaptation is limited by insufficient clinical information, costs, clinician education, and in some health systems, historical reimbursement rules.
Authors
- Jan G.M.C. Damoiseaux (ORCID: https://orcid.org/0000-0003-4007-6985)
- Ulrich Specks (ORCID: https://orcid.org/0000-0002-6559-1206)
- Andrew P McLean‐Tooke (ORCID: https://orcid.org/0000-0003-4307-0837)
- Shaun S. C. Ho (ORCID: https://orcid.org/0000-0002-5690-6560)
- Christine S. Bundell (ORCID: https://orcid.org/0000-0002-6372-1513)
- Saša Čučnik (ORCID: https://orcid.org/0000-0002-6686-9126)
- David McDonald (ORCID: https://orcid.org/0000-0002-5431-2531)
- Yang Tran (ORCID: https://orcid.org/0009-0003-6670-5046)
- Kerri M. Prain
- Catherine Yu (ORCID: https://orcid.org/0009-0008-1462-0602)
Institutions
- Royal Children's Hospital (AU)
- Mayo Clinic (US)
- University of Ljubljana (SI)
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Royal Prince Alfred Hospital (AU)
- Maastricht University Medical Centre (NL)
- Princess Margaret Hospital for Children (AU)
- Ljubljana University Medical Centre (SI)
- Sir Charles Gairdner Hospital (AU)
- Westmead Hospital (AU)
- Maastricht University (NL)
- St Vincent's Hospital Melbourne (AU)
- Queen Elizabeth II Medical Centre (AU)
- Slovenian Centre of Excellence for Space Sciences and Technologies (SI)
- Murdoch Children's Research Institute (AU)
- Pathwest Laboratory Medicine (AU)
Publication Details
- Journal
- Rheumatology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1093/rheumatology/keag650
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00